Wasaburo Koizumi

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

Wasaburo Koizumi, Hiroyuki Narahara, Takuo Hara et al. · The Lancet Oncology · 2008 · 1.9K citations

Medicine, Oncology, Chemotherapy +7

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

Narikazu Boku, Seiichiro Yamamoto, Haruhiko Fukuda et al. · The Lancet Oncology · 2009 · 592 citations

Medicine, Oncology, Pharmacology +13

Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric Cancer

Wasaburo Koizumi, Minoru Kurihara, Shuji Nakano et al. · Oncology · 2000 · 440 citations

Medicine, Oncology, Pharmacology +15

Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer

Wasaburo Koizumi, Satoshi Tanabe, Katsunori Saigenji et al. · British Journal of Cancer · 2003 · 249 citations · Full text

Medicine, Oncology, Pharmacology +17

Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial

Kohei Shitara, Atsuo Takashima, Kazumasa Fujitani et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 219 citations

Medicine, Oncology, Pharmacology +7